These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. [Determination of lymphocyte subpopulations and their activation status in patients with rheumatoid arthritis treated with plasma exchange and pulse therapy]. Sauer H; Häntzschel H; Seidel W Z Gesamte Inn Med; 1991 Dec; 46(18):677-82. PubMed ID: 1796618 [TBL] [Abstract][Full Text] [Related]
15. Aggressive treatment with pulse methylprednisolone or plasma exchange is justified in rapidly progressive glomerulonephritis. Stevens ME; McConnell M; Bone JM Proc Eur Dial Transplant Assoc; 1983; 19():724-31. PubMed ID: 6878261 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of chronic connective tissue diseases with cytostatics]. Deicher H; Fricke R; Krull P Minerva Med; 1970 Jul; 61(55):3040-53. PubMed ID: 4987808 [No Abstract] [Full Text] [Related]
17. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis. Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482 [TBL] [Abstract][Full Text] [Related]
18. [Strategy of immunosuppressants usage for subjects with loss of renal function and infection control on RPGN]. Yoshida M Nihon Jinzo Gakkai Shi; 2009; 51(2):114-20. PubMed ID: 19378797 [No Abstract] [Full Text] [Related]